On Friday, President Donald Trump signed an executive order that would shift power over grantmaking away from career ...

Alzheimer’s is one of the biggest killers in the UK, and as of yet there is no cure. However, early medical trials of a new ...

Human monoclonal antibodies targeting rabies glycoprotein have been proposed as a potential alternative to rabies immunoglobulin to neutralise rabies virus at the wound site until sufficient virus ...

The RESONATE-2 trial reveals ibrutinib's long-term efficacy and safety in treating CLL/SLL, especially for high-risk patients ...

First, data and digital business services company, has been recognised as a Major Contender in Everest Group’s Life Sciences Digital Services PEAK Matrix® Assessment 2025. This recognition reflects ...

In this week’s edition of InnovationRx, we look at a biotech entrepreneur treating a rare genetic disease, new tech aimed at ...

Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive ...

Today’s Forbes CFO newsletter focuses on Aradhana Sarin’s journey from treating patients to becoming what she calls a ...

Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive surprises than negative ones.

NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0) a premier artificial intelligence (AI) company transforming clinical trials today ...

An estimated 1·6 million adolescents (aged 10–19 years) were living with HIV in 2024, with adolescents having lower rates of virological suppression and increased rates of antiretroviral drug ...